Synthesis and autoradiographic evaluation of a novel high-affinity Tc-99m ligand for the 5-HT2A receptor.
暂无分享,去创建一个
M. Scheunemann | P. Brust | H. Spies | B. Johannsen | H. Pertz | H. Pietzsch | R. Syhre | S. Elz | S. Seifert | M. Kretzschmar
[1] J. Katzenellenbogen,et al. Technetium-99m-labeled receptor-specific small-molecule radiopharmaceuticals: recent developments and encouraging results. , 1997, Nuclear medicine and biology.
[2] A. Luxen,et al. In vivo binding of [18F]altanserin to rat brain 5HT2 receptors: a film and electronic autoradiographic study. , 1997, Nuclear medicine and biology.
[3] H. Spies,et al. Advances in technetium chemistry towards 99mTc receptor imaging agents , 1997 .
[4] J. Arias-Montaño,et al. Histamine H1 receptors and inositol phosphate formation in rat thalamus , 1997, Neuroscience Letters.
[5] H. Schild,et al. SOME QUANTITATIVE USES OF DRUG ANTAGONISTS , 1997, British journal of pharmacology and chemotherapy.
[6] H. Kung,et al. Tc-99m-labeled tropanes as dopamine transporter imaging agents. , 1996, Bioconjugate chemistry.
[7] J S Fowler,et al. PET evaluation of the dopamine system of the human brain. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] M. Scheunemann,et al. Technetium(V) and rhenium(V) complexes for 5-HT2A serotonin receptor binding: structure-affinity considerations. , 1996, Nuclear medicine and biology.
[9] J. Baron,et al. Specific in vivo binding in the rat brain of [18F]RP 62203: a selective 5-HT2A receptor radioligand for positron emission tomography. , 1996, Nuclear medicine and biology.
[10] H. Kung,et al. First Example of a 99mTc Complex as a Dopamine Transporter Imaging Agent , 1995 .
[11] H. Pertz,et al. In‐vitro Pharmacology of Sarpogrelate and the Enantiomers of its Major Metabolite: 5‐HT2A Receptor Specificity, Stereoselectivity and Modulation of Ritanserin‐induced Depression of 5‐HT Contractions in Rat Tail Artery , 1995, The Journal of pharmacy and pharmacology.
[12] H. Stark,et al. Novel histamine H3 receptor antagonists: affinities in an H3 receptor binding assay and potencies in two functional H3 receptor models , 1994, British journal of pharmacology.
[13] P. Hrdina,et al. Chronic fluoxetine treatment upregulates 5‐HT uptake sites and 5‐HT2 receptors in rat brain: An autoradiographic study , 1993, Synapse.
[14] C. Lemaire,et al. Fluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[15] J. Palacios,et al. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors , 1985, Brain Research.
[16] P. Bradley,et al. Tryptamine‐induced vasoconstrictor responses in rat caudal arteries are mediated predominantly via 5‐hydroxytryptamine receptors , 1985, British journal of pharmacology.
[17] M. Folstein,et al. EFFECTS OF AGE ON DOPAMINE AND SEROTONIN RECEPTORS MEASURED BY POSITRON TOMOGRAPHY IN THE LIVING HUMAN BRAIN , 1984, Science.
[18] J. Leysen,et al. [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. , 1982, Molecular pharmacology.
[19] J. V. van Beek,et al. Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors. , 1981, The Journal of pharmacology and experimental therapeutics.
[20] C. Pittman,et al. Reaction of lactones and thiolactones with 2-amino-2-methyl-1-propanol. Synthesis of 2-substituted 2-oxazolines , 1976 .
[21] M. Scheunemann,et al. No carrier added preparations of ‘3 + 1’ mixed-ligand 99mTc complexes , 1998 .
[22] S. Elz,et al. Preparation and In Vitro Pharmacology of 5‐HT4 Receptor Ligands. Partial Agonism and Antagonism of Metoclopramide Analogous Benzoic Esters , 1995, Archiv der Pharmazie.
[23] H. Spies,et al. Neutral oxorhenium(V) complexes with tridentate dithiolates and monodentate alkane- or arene-thiolate coligands , 1995 .
[24] D. Middlemiss,et al. Chapter 5. Drugs Acting at Central 5-Hydroxytryptamine Receptors , 1986 .
[25] J. Fleisch,et al. On the measurement of vascular and respiratory smooth muscle responses in vitro. , 1977, Blood vessels.
[26] R. Furchgott. The Classification of Adrenoceptors (Adrenergic Receptors). An Evaluation from the Standpoint of Receptor Theory , 1972 .
[27] G. Wilkinson,et al. 204. Amine, phosphine, arsine, and stibine complexes of rhenium-(III), -(IV), and -(V) , 1964 .
[28] Van Rossum Jm. Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. , 1963 .
[29] J. Harley-Mason. 60. Some aliphatic thiols and their derivatives. Part I. Aliphatic mercaptoamines , 1947 .